In dermatomyositis, C3 complement activation ... Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur in predisposed patients who receive IGIV products, including Octagam ...

Results: Disease-related death occurred in at least 10% of the patients ... Jo-1 antibodies predicted the persistent use of drugs (OR 4.4, 95% CI 1.3 to 15.0). Conclusions: Dermatomyositis and ...

Background: Juvenile dermatomyositis (JDM) is a systemic autoimmune disease ... and high risk for progression to multiple organ dysfunction, shock and often death. It typically arises as a ...

In Maria, Angelina Jolie channels her own celebrity and understanding of fame, the crippling demands of beauty and age, and a woman's need to author her own narrative at whatever cost.

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

drugs like docetaxel have been reported to induce immunogenic cell death, thereby enhancing the presentation of tumor antigens to the immune system (26). This could potentially trigger or exacerbate ...

including permanent dialysis and death. Early recognition and treatment with angiotensin-converting enzyme inhibitors are important in the effective management of SRC, though given the continuing ...

dermatomyositis, or psoriatic arthritis between the groups. The study also explored variations in risk based on specific ICI therapies. Subgroup analysis compared cytotoxic T-lymphocyte-associated ...

Dermatomyositis presenting in the elderly is more likely ... Presumably this reflects underlying neuronal cell death and so if treatment is to have any benefit it needs to be given expeditiously ...

Treatment with dazukibart, a monoclonal antibody targeting interferon beta, yielded a rapid reduction in dermatomyositis disease activity in adults with skin-predominant and muscle-predominant ...

CDASI-A score at 12 weeks was significantly lower in dazukibart 600 mg versus placebo, suggesting reduced morbidity. 2.